Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q72770340 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241020233037.0 | ||
008 | 241020nneanz||abbn n and d | ||
035 | ‡a (WKP)Q72770340 | ||
024 | ‡a 0000-0002-5411-4498 ‡2 orcid | ||
024 | ‡a 14058460100 ‡2 scopus | ||
024 | ‡a 57000043500 ‡2 scopus | ||
035 | ‡a (OCoLC)Q72770340 | ||
100 | 0 | ‡a Maria S Navarrete ‡c researcher ‡9 en | |
375 | ‡a 2 ‡2 iso5218 | ||
400 | 0 | ‡a M S Navarrete ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neck | ||
670 | ‡a Author's Copper surfaces are associated with significantly lower concentrations of bacteria on selected surfaces within a pediatric intensive care unit. | ||
670 | ‡a Author's Cost-effectiveness of universal childhood hepatitis A vaccination in Chile | ||
670 | ‡a Author's Impact of rotavirus infections on outpatient clinic visits in chile. | ||
670 | ‡a Author's Potential effectiveness of copper surfaces in reducing health care-associated infection rates in a pediatric intensive and intermediate care unit: A nonrandomized controlled trial | ||
670 | ‡a Author's [Universal health coverage assessment based on national socioeconomic characterization surveys]. | ||
670 | ‡a Author's Vitamin B12 injections in patients treated with zidovudine | ||
909 | ‡a (orcid) 0000000254114498 ‡9 1 | ||
909 | ‡a (scopus) 14058460100 ‡9 1 | ||
909 | ‡a (scopus) 57000043500 ‡9 1 | ||
919 | ‡a potentialeffectivenessofcoppersurfacesinreducinghealthcareassociatedinfectionratesinapediatricintensiveandintermediatecareunitanonrandomizedcontrolledtrial ‡A Potential effectiveness of copper surfaces in reducing health care-associated infection rates in a pediatric intensive and intermediate care unit: A nonrandomized controlled trial ‡9 1 | ||
919 | ‡a universalhealthcoverageassessmentbasedonnationalsocioeconomiccharacterizationsurveys ‡A [Universal health coverage assessment based on national socioeconomic characterization surveys]. ‡9 1 | ||
919 | ‡a vitaminb12injectionsinpatientstreatedwithzidovudine ‡A Vitamin B12 injections in patients treated with zidovudine ‡9 1 | ||
919 | ‡a phase2studyofpiritreximinpatientswithadvancedsquamouscellcarcinomaoftheheadandneck ‡A A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neck ‡9 1 | ||
919 | ‡a coppersurfacesareassociatedwithsignificantlylowerconcentrationsofbacteriaonselectedsurfaceswithinapediatricintensivecareunit ‡A Copper surfaces are associated with significantly lower concentrations of bacteria on selected surfaces within a pediatric intensive care unit. ‡9 1 | ||
919 | ‡a costeffectivenessofuniversalchildhoodhepatitisavaccinationinchile ‡A Cost-effectiveness of universal childhood hepatitis A vaccination in Chile ‡9 1 | ||
919 | ‡a impactofrotavirusinfectionsonoutpatientclinicvisitsinchile ‡A Impact of rotavirus infections on outpatient clinic visits in chile. ‡9 1 | ||
946 | ‡a a ‡9 1 | ||
996 | ‡2 DNB|1157270638 | ||
996 | ‡2 NUKAT|n 2015045169 | ||
996 | ‡2 LC|no2019089691 | ||
996 | ‡2 LC|no2009154992 | ||
996 | ‡2 LC|no2014093936 | ||
996 | ‡2 BNE|XX1056782 | ||
996 | ‡2 BNE|XX6101408 | ||
996 | ‡2 DNB|139582304 | ||
996 | ‡2 BNF|15518850 | ||
996 | ‡2 BNC|981058527023306706 | ||
996 | ‡2 DBC|87097947587883 | ||
996 | ‡2 BNF|14597355 | ||
996 | ‡2 ISNI|0000000108886051 | ||
996 | ‡2 BNCHL|10000000000000000106952 | ||
996 | ‡2 DNB|1056826185 | ||
996 | ‡2 SUDOC|083755845 | ||
996 | ‡2 RERO|A003568539 | ||
996 | ‡2 ISNI|0000000117866458 | ||
996 | ‡2 PLWABN|9810649244905606 | ||
996 | ‡2 CAOONL|ncf10676897 | ||
996 | ‡2 ISNI|0000000080088444 | ||
996 | ‡2 LC|no2021079815 | ||
996 | ‡2 DNB|1056557117 | ||
996 | ‡2 BNCHL|10000000000000000851308 | ||
996 | ‡2 ISNI|0000000031701855 | ||
996 | ‡2 LC|n 79118519 | ||
996 | ‡2 CAOONL|ncf11524973 | ||
996 | ‡2 LC|n 93117008 | ||
996 | ‡2 BNC|981058526764906706 | ||
996 | ‡2 ISNI|0000000108887564 | ||
996 | ‡2 NTA|070208565 | ||
996 | ‡2 LC|n 95109554 | ||
996 | ‡2 RERO|A016861530 | ||
996 | ‡2 ISNI|0000000072377262 | ||
996 | ‡2 DNB|1056763396 | ||
996 | ‡2 ISNI|0000000118422779 | ||
996 | ‡2 J9U|987007594729005171 | ||
996 | ‡2 SUDOC|03043968X | ||
996 | ‡2 NTA|304126926 | ||
996 | ‡2 LC|no2020149444 | ||
996 | ‡2 BNE|XX5767103 | ||
996 | ‡2 LC|n 99005754 | ||
996 | ‡2 LC|nr2003005290 | ||
996 | ‡2 CAOONL|ncf13698605 | ||
996 | ‡2 BNC|981058507702706706 | ||
996 | ‡2 LC|n 90675563 | ||
996 | ‡2 LC|nb2022010698 | ||
996 | ‡2 DNB|1158232926 | ||
996 | ‡2 LC|nb2005012076 | ||
996 | ‡2 BNCHL|10000000000000000062093 | ||
996 | ‡2 BNC|981058608464906706 | ||
996 | ‡2 ISNI|0000000083880293 | ||
996 | ‡2 ISNI|0000000037551894 | ||
996 | ‡2 LC|no2017114607 | ||
996 | ‡2 DNB|1308144776 | ||
996 | ‡2 NUKAT|n 2008077791 | ||
996 | ‡2 BNF|16932742 | ||
996 | ‡2 BNC|981060024853706706 | ||
996 | ‡2 ISNI|0000000436219901 | ||
996 | ‡2 ISNI|0000000079721791 | ||
996 | ‡2 PLWABN|9812829460305606 | ||
996 | ‡2 BNF|12185389 | ||
996 | ‡2 BNE|XX4581891 | ||
996 | ‡2 PLWABN|9810622394805606 | ||
996 | ‡2 LC|no2016114014 | ||
996 | ‡2 LC|n 95095676 | ||
996 | ‡2 SUDOC|066882125 | ||
996 | ‡2 NUKAT|n 2010086765 | ||
996 | ‡2 BNC|981058514344006706 | ||
996 | ‡2 BNE|XX963717 | ||
996 | ‡2 DNB|111581915 | ||
996 | ‡2 BNF|14649710 | ||
996 | ‡2 J9U|987010650091305171 | ||
996 | ‡2 PLWABN|9810690895405606 | ||
996 | ‡2 LC|n 93071594 | ||
996 | ‡2 PLWABN|9810684085605606 | ||
996 | ‡2 LC|no2019188450 | ||
996 | ‡2 SUDOC|245317473 | ||
996 | ‡2 DNB|1057141984 | ||
996 | ‡2 DNB|1047412128 | ||
996 | ‡2 BNE|XX1645105 | ||
996 | ‡2 LC|no2009139039 | ||
996 | ‡2 DNB|134533222X | ||
996 | ‡2 SUDOC|121596524 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |